The Valley Desk

NCT00770081 · Interventional trial

Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency (28-week Extension Study)

Overall registry status Completed

Phase 3

Conditions Diabetes Mellitus, Type 2, Renal Insufficiency

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov